Connect with us
Algernon Pharmaceuticals Inc. is a Canadian clinical-stage drug development company with a promising new treatment for post-stroke recovery based on sub-psychedelic doses of DMT. The company...
Some approaches to developing pharmaceuticals are more efficient than others. Algernon Pharmaceuticals provides a perfect example of the efficient way, with a large portion of its...
Stroke deaths, and costs, rise every year. Complicated by the need to determine the type of stroke, treatment currently fails to save many and offers little...
The pharmaceutical industry is famous for its high R&D costs. But there are low-risk, capital-efficient alternatives to new drug development. Algernon Pharmaceuticals Inc. is exploring one...